Artificial intelligence fingerprints gut flora, linking clusters of microbial species with type 1 diabetes development.
Read More »Improve Cardiovascular Outcomes with DPP4 Inhibitors
DPP4 inhibitors may restore the normal functioning of vascular endothelium in patients who require insulin treatment.
Read More »Preventing Diabetes with Antihypertensives
Researchers showed that elevated blood pressure is a modifiable risk factor for new-onset type 2 diabetes.
Read More »Black & Hispanic Americans Develop Diabetes Earlier in Life
The mean age at diagnosis of diabetes for non-Hispanic Black and Hispanic adults was 4-7 years earlier than for non-Hispanic white adults.
Read More »Processed Versus Intact Whole Grains and Glycemic Control
Many foods are marked with the whole-grain stamp of approval, but are these products equivalent in terms of glycemic control?
Read More »Preventing Misdiagnosis between Type 1 and Type 2
A program testing type 1 diabetes patients’ C-peptide levels found that approximately half of the group had a different form of diabetes.
Read More »New Screening Tool to Prevent Mortality from Complications of Foot Ulcers
Risk factors associated with diabetic foot ulcers (DFU) are easily found in medical records, giving clinicians a tool for early detection.
Read More »Why Fractures and Falls in Type 2 Diabetes?
A prospective study found an increased risk for fractures and falls among older women with type 2 diabetes.
Read More »Efpeglenatide Has Cardiovascular and Renal Benefit Outcomes in Type 2 Diabetes
Efpeglenatide has proven to significantly reduce several risk factors for cardiovascular and kidney disease.
Read More »Linagliptin and Glimepiride
According to current research, linagliptin had a significantly lower risk of hypoglycemia and adverse events in geriatric patients with type 2 diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.